Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

protein glycosylation as a diagnostic and prognostic marker of chronic inflammatory gastrointestinal and liver diseases.

Verhelst X, Dias AM, Colombel JF, Vermeire S, Van Vlierberghe H, Callewaert N, Pinho SS.

Gastroenterology. 2019 Oct 15. pii: S0016-5085(19)41451-0. doi: 10.1053/j.gastro.2019.08.060. [Epub ahead of print] Review.

2.

A guide to Mycobacterium mutagenesis.

Borgers K, Vandewalle K, Festjens N, Callewaert N.

FEBS J. 2019 Oct;286(19):3757-3774. doi: 10.1111/febs.15041. Epub 2019 Aug 26. Review.

PMID:
31419030
3.

The generation and use of recombinant extracellular vesicles as biological reference material.

Geeurickx E, Tulkens J, Dhondt B, Van Deun J, Lippens L, Vergauwen G, Heyrman E, De Sutter D, Gevaert K, Impens F, Miinalainen I, Van Bockstal PJ, De Beer T, Wauben MHM, Nolte-'t-Hoen ENM, Bloch K, Swinnen JV, van der Pol E, Nieuwland R, Braems G, Callewaert N, Mestdagh P, Vandesompele J, Denys H, Eyckerman S, De Wever O, Hendrix A.

Nat Commun. 2019 Jul 23;10(1):3288. doi: 10.1038/s41467-019-11182-0.

4.

The potential of glycomics as prognostic biomarkers in liver disease and liver transplantation.

Verhelst X, Geerts A, Callewaert N, Van Vlierberghe H.

Acta Gastroenterol Belg. 2019 Apr-Jun;82(2):309-313. Review.

PMID:
31314193
5.

Reference genome and comparative genome analysis for the WHO reference strain for Mycobacterium bovis BCG Danish, the present tuberculosis vaccine.

Borgers K, Ou JY, Zheng PX, Tiels P, Van Hecke A, Plets E, Michielsen G, Festjens N, Callewaert N, Lin YC.

BMC Genomics. 2019 Jul 8;20(1):561. doi: 10.1186/s12864-019-5909-5.

6.

SapM mutation to improve the BCG vaccine: Genomic, transcriptomic and preclinical safety characterization.

Festjens N, Vandewalle K, Houthuys E, Plets E, Vanderschaeghe D, Borgers K, Van Hecke A, Tiels P, Callewaert N.

Vaccine. 2019 Jun 12;37(27):3539-3551. doi: 10.1016/j.vaccine.2019.05.022. Epub 2019 May 20.

PMID:
31122861
7.

Characterization of Human Recombinant N-Acetylgalactosamine-6-Sulfate Sulfatase Produced in Pichia pastoris as Potential Enzyme for Mucopolysaccharidosis IVA Treatment.

Rodríguez-López A, Pimentel-Vera LN, Espejo-Mojica AJ, Van Hecke A, Tiels P, Tomatsu S, Callewaert N, Alméciga-Díaz CJ.

J Pharm Sci. 2019 Aug;108(8):2534-2541. doi: 10.1016/j.xphs.2019.03.034. Epub 2019 Apr 5.

PMID:
30959056
8.

Yeast-secreted, dried and food-admixed monomeric IgA prevents gastrointestinal infection in a piglet model.

Virdi V, Palaci J, Laukens B, Ryckaert S, Cox E, Vanderbeke E, Depicker A, Callewaert N.

Nat Biotechnol. 2019 May;37(5):527-530. doi: 10.1038/s41587-019-0070-x. Epub 2019 Apr 1.

9.

N-Linked Glycosylation and Near-Infrared Spectroscopy in the Diagnosis of Prostate Cancer.

Vermassen T, De Bruyne S, Himpe J, Lumen N, Callewaert N, Rottey S, Delanghe J.

Int J Mol Sci. 2019 Mar 29;20(7). pii: E1592. doi: 10.3390/ijms20071592.

10.

Prostate Protein N-Glycosylation Profiling by Means of DNA Sequencer-Assisted Fluorophore-Assisted Carbohydrate Electrophoresis.

Vermassen T, Callewaert N, Rottey S, Delanghe JR.

Methods Mol Biol. 2019;1972:235-250. doi: 10.1007/978-1-4939-9213-3_17.

PMID:
30847796
11.

Customized protein glycosylation to improve biopharmaceutical function and targeting.

Van Landuyt L, Lonigro C, Meuris L, Callewaert N.

Curr Opin Biotechnol. 2018 Dec 13;60:17-28. doi: 10.1016/j.copbio.2018.11.017. [Epub ahead of print] Review.

PMID:
30554064
12.

Engineering of Yeast Glycoprotein Expression.

De Wachter C, Van Landuyt L, Callewaert N.

Adv Biochem Eng Biotechnol. 2018 Nov 7. doi: 10.1007/10_2018_69. [Epub ahead of print]

PMID:
30397726
13.

Mechanical strain determines the site-specific localization of inflammation and tissue damage in arthritis.

Cambré I, Gaublomme D, Burssens A, Jacques P, Schryvers N, De Muynck A, Meuris L, Lambrecht S, Carter S, de Bleser P, Saeys Y, Van Hoorebeke L, Kollias G, Mack M, Simoens P, Lories R, Callewaert N, Schett G, Elewaut D.

Nat Commun. 2018 Nov 5;9(1):4613. doi: 10.1038/s41467-018-06933-4.

14.

Endoglycosidase S Enables a Highly Simplified Clinical Chemistry Procedure for Direct Assessment of Serum IgG Undergalactosylation in Chronic Inflammatory Disease.

Vanderschaeghe D, Meuris L, Raes T, Grootaert H, Van Hecke A, Verhelst X, Van de Velde F, Lapauw B, Van Vlierberghe H, Callewaert N.

Mol Cell Proteomics. 2018 Dec;17(12):2508-2517. doi: 10.1074/mcp.TIR118.000740. Epub 2018 Sep 6.

PMID:
30190373
15.

Human tissue-engineered skeletal muscle: a novel 3D in vitro model for drug disposition and toxicity after intramuscular injection.

Gholobova D, Gerard M, Decroix L, Desender L, Callewaert N, Annaert P, Thorrez L.

Sci Rep. 2018 Aug 15;8(1):12206. doi: 10.1038/s41598-018-30123-3.

16.

Capturing the 'ome': the expanding molecular toolbox for RNA and DNA library construction.

Boone M, De Koker A, Callewaert N.

Nucleic Acids Res. 2018 Apr 6;46(6):2701-2721. doi: 10.1093/nar/gky167. Review.

17.

A pragmatic bottom-up approach to harmonize the units of clinical chemistry tests among Belgian clinical laboratories, focusing on immunoassays.

Demarteau M, Cammaert P, Vandevelde NM, Callewaert N, Coucke W, China B, Verstraete AG.

Clin Chem Lab Med. 2018 Dec 19;57(1):12-19. doi: 10.1515/cclm-2017-0824.

18.

Glycome Patterns of Perfusate in Livers Before Transplantation Associate With Primary Nonfunction.

Verhelst X, Geerts A, Jochmans I, Vanderschaeghe D, Paradissis A, Vanlander A, Berrevoet F, Dahlqvist G, Nevens F, Pirenne J, Rogiers X, Callewaert N, Troisi RI, Van Vlierberghe H.

Gastroenterology. 2018 Apr;154(5):1361-1368. doi: 10.1053/j.gastro.2017.12.027. Epub 2018 Jan 6.

PMID:
29309776
19.

Release of urinary extracellular vesicles in prostate cancer is associated with altered urinary N-glycosylation profile.

Vermassen T, D'Herde K, Jacobus D, Van Praet C, Poelaert F, Lumen N, Callewaert N, Decaestecker K, Villeirs G, Hoebeke P, Van Belle S, Rottey S, Delanghe J.

J Clin Pathol. 2017 Oct;70(10):838-846. doi: 10.1136/jclinpath-2016-204312. Epub 2017 Mar 30.

PMID:
28360190
20.

An endoplasmic reticulum-engineered yeast platform for overproduction of triterpenoids.

Arendt P, Miettinen K, Pollier J, De Rycke R, Callewaert N, Goossens A.

Metab Eng. 2017 Mar;40:165-175. doi: 10.1016/j.ymben.2017.02.007. Epub 2017 Feb 16.

PMID:
28216107
21.

Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies.

Van den Hoecke S, Ehrhardt K, Kolpe A, El Bakkouri K, Deng L, Grootaert H, Schoonooghe S, Smet A, Bentahir M, Roose K, Schotsaert M, Schepens B, Callewaert N, Nimmerjahn F, Staeheli P, Hengel H, Saelens X.

J Virol. 2017 Mar 13;91(7). pii: e02500-16. doi: 10.1128/JVI.02500-16. Print 2017 Apr 1.

22.

A Glycomics-Based Test Predicts the Development of Hepatocellular Carcinoma in Cirrhosis.

Verhelst X, Vanderschaeghe D, Castéra L, Raes T, Geerts A, Francoz C, Colman R, Durand F, Callewaert N, Van Vlierberghe H.

Clin Cancer Res. 2017 Jun 1;23(11):2750-2758. doi: 10.1158/1078-0432.CCR-16-1500. Epub 2016 Dec 16.

23.

Modular Integrated Secretory System Engineering in Pichia pastoris To Enhance G-Protein Coupled Receptor Expression.

Claes K, Vandewalle K, Laukens B, Laeremans T, Vosters O, Langer I, Parmentier M, Steyaert J, Callewaert N.

ACS Synth Biol. 2016 Oct 21;5(10):1070-1075. Epub 2016 May 20.

PMID:
27176489
24.

Outcome Indicators on Interprofessional Collaboration Interventions for Elderly.

Tsakitzidis G, Timmermans O, Callewaert N, Verhoeven V, Lopez-Hartmann M, Truijen S, Meulemans H, Van Royen P.

Int J Integr Care. 2016 May 16;16(2):5. doi: 10.5334/ijic.2017.

25.

A simple colorimetric assay for measuring fructosamine 3 kinase activity.

Cikomola JC, Kishabongo AS, Vandepoele K, Mulder M, Katchunga PB, Laukens B, Schie LV, Grootaert H, Callewaert N, Speeckaert MM, Delanghe JR.

Clin Chem Lab Med. 2017 Jan 1;55(1):154-159. doi: 10.1515/cclm-2016-0441.

PMID:
27394048
26.

Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin-activatable fibrinolysis inhibitor activation and activated thrombin-activatable fibrinolysis inhibitor activity.

Zhou X, Weeks SD, Ameloot P, Callewaert N, Strelkov SV, Declerck PJ.

J Thromb Haemost. 2016 Aug;14(8):1629-38. doi: 10.1111/jth.13381. Epub 2016 Jul 27.

27.

Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies.

Schotsaert M, Ysenbaert T, Smet A, Schepens B, Vanderschaeghe D, Stegalkina S, Vogel TU, Callewaert N, Fiers W, Saelens X.

Sci Rep. 2016 Apr 13;6:24402. doi: 10.1038/srep24402.

28.

Synthetic biology for production of natural and new-to-nature terpenoids in photosynthetic organisms.

Arendt P, Pollier J, Callewaert N, Goossens A.

Plant J. 2016 Jul;87(1):16-37. doi: 10.1111/tpj.13138. Epub 2016 Mar 7. Review.

29.

Influenza-binding sialylated polymer coated gold nanoparticles prepared via RAFT polymerization and reductive amination.

Zhang Z, Schepens B, Nuhn L, Saelens X, Schotsaert M, Callewaert N, De Rycke R, Zhang Q, Moins S, Benali S, Mespouille L, Hoogenboom R, De Geest BG.

Chem Commun (Camb). 2016 Feb 25;52(16):3352-5. doi: 10.1039/c6cc00501b.

PMID:
26823186
30.

Using GlycoDelete to produce proteins lacking plant-specific N-glycan modification in seeds.

Piron R, Santens F, De Paepe A, Depicker A, Callewaert N.

Nat Biotechnol. 2015 Nov;33(11):1135-7. doi: 10.1038/nbt.3359. No abstract available.

PMID:
26544140
31.

Participant evaluation of an education module on interprofessional collaboration for students in healthcare studies.

Tsakitzidis G, Timmermans O, Callewaert N, Truijen S, Meulemans H, Van Royen P.

BMC Med Educ. 2015 Oct 27;15:188. doi: 10.1186/s12909-015-0477-0.

32.

A scalable low-cost cGMP process for clinical grade production of the HIV inhibitor 5P12-RANTES in Pichia pastoris.

Cerini F, Gaertner H, Madden K, Tolstorukov I, Brown S, Laukens B, Callewaert N, Harner JC, Oommen AM, Harms JT, Sump AR, Sealock RC, Peterson DJ, Johnson SK, Abramson SB, Meagher M, Offord R, Hartley O.

Protein Expr Purif. 2016 Mar;119:1-10. doi: 10.1016/j.pep.2015.10.011. Epub 2015 Oct 24.

33.

Monitoring the patient response as an alternative to commercial negative quality control in infectious serology.

Wils J, Boudewijns M, Vandermarliere M, Callewaert N.

J Clin Virol. 2015 Nov;72:30-5. doi: 10.1016/j.jcv.2015.08.016. Epub 2015 Sep 9.

PMID:
26363142
34.

Structure and Assembly Mechanism of the Signaling Complex Mediated by Human CSF-1.

Felix J, De Munck S, Verstraete K, Meuris L, Callewaert N, Elegheert J, Savvides SN.

Structure. 2015 Sep 1;23(9):1621-1631. doi: 10.1016/j.str.2015.06.019. Epub 2015 Jul 30.

35.

Engineering the Pichia pastoris N-Glycosylation Pathway Using the GlycoSwitch Technology.

Laukens B, De Wachter C, Callewaert N.

Methods Mol Biol. 2015;1321:103-22. doi: 10.1007/978-1-4939-2760-9_8.

PMID:
26082218
36.

Characterization of genome-wide ordered sequence-tagged Mycobacterium mutant libraries by Cartesian Pooling-Coordinate Sequencing.

Vandewalle K, Festjens N, Plets E, Vuylsteke M, Saeys Y, Callewaert N.

Nat Commun. 2015 May 11;6:7106. doi: 10.1038/ncomms8106.

37.

Production, purification and crystallization of a trans-sialidase from Trypanosoma vivax.

Haynes CL, Ameloot P, Remaut H, Callewaert N, Sterckx YG, Magez S.

Acta Crystallogr F Struct Biol Commun. 2015 May;71(Pt 5):577-85. doi: 10.1107/S2053230X15002496. Epub 2015 Apr 21.

38.

Membrane protein expression and analysis in yeast.

Claes K, Guerfal M, Callewaert N.

Methods Enzymol. 2015;556:123-40. doi: 10.1016/bs.mie.2014.12.010. Epub 2015 Mar 20.

PMID:
25857780
39.

Routine serum creatinine measurements: how well do we perform?

Hoste L, Deiteren K, Pottel H, Callewaert N, Martens F.

BMC Nephrol. 2015 Feb 14;16:21. doi: 10.1186/s12882-015-0012-x.

40.

Comparison of VHH-Fc antibody production in Arabidopsis thaliana, Nicotiana benthamiana and Pichia pastoris.

De Meyer T, Laukens B, Nolf J, Van Lerberge E, De Rycke R, De Beuckelaer A, De Buck S, Callewaert N, Depicker A.

Plant Biotechnol J. 2015 Sep;13(7):938-47. doi: 10.1111/pbi.12330. Epub 2015 Jan 30.

41.

Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.

Bontempi IA, Vicco MH, Cabrera G, Villar SR, González FB, Roggero EA, Ameloot P, Callewaert N, Pérez AR, Marcipar IS.

Vaccine. 2015 Mar 3;33(10):1274-83. doi: 10.1016/j.vaccine.2015.01.044. Epub 2015 Jan 25.

PMID:
25625671
42.

Engineering yeast for producing human glycoproteins: where are we now?

Laukens B, De Visscher C, Callewaert N.

Future Microbiol. 2015;10(1):21-34. doi: 10.2217/fmb.14.104.

PMID:
25598335
43.

Urinary prostate protein glycosylation profiling as a diagnostic biomarker for prostate cancer.

Vermassen T, Van Praet C, Lumen N, Decaestecker K, Vanderschaeghe D, Callewaert N, Villeirs G, Hoebeke P, Van Belle S, Rottey S, Delanghe J.

Prostate. 2015 Feb 15;75(3):314-22. doi: 10.1002/pros.22918. Epub 2014 Oct 30.

PMID:
25358590
44.

Genome dynamics of the human embryonic kidney 293 lineage in response to cell biology manipulations.

Lin YC, Boone M, Meuris L, Lemmens I, Van Roy N, Soete A, Reumers J, Moisse M, Plaisance S, Drmanac R, Chen J, Speleman F, Lambrechts D, Van de Peer Y, Tavernier J, Callewaert N.

Nat Commun. 2014 Sep 3;5:4767. doi: 10.1038/ncomms5767.

45.

GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins.

Meuris L, Santens F, Elson G, Festjens N, Boone M, Dos Santos A, Devos S, Rousseau F, Plets E, Houthuys E, Malinge P, Magistrelli G, Cons L, Chatel L, Devreese B, Callewaert N.

Nat Biotechnol. 2014 May;32(5):485-9. doi: 10.1038/nbt.2885. Epub 2014 Apr 20.

PMID:
24752077
46.

Multiple phenotypes in phosphoglucomutase 1 deficiency.

Tegtmeyer LC, Rust S, van Scherpenzeel M, Ng BG, Losfeld ME, Timal S, Raymond K, He P, Ichikawa M, Veltman J, Huijben K, Shin YS, Sharma V, Adamowicz M, Lammens M, Reunert J, Witten A, Schrapers E, Matthijs G, Jaeken J, Rymen D, Stojkovic T, Laforêt P, Petit F, Aumaître O, Czarnowska E, Piraud M, Podskarbi T, Stanley CA, Matalon R, Burda P, Seyyedi S, Debus V, Socha P, Sykut-Cegielska J, van Spronsen F, de Meirleir L, Vajro P, DeClue T, Ficicioglu C, Wada Y, Wevers RA, Vanderschaeghe D, Callewaert N, Fingerhut R, van Schaftingen E, Freeze HH, Morava E, Lefeber DJ, Marquardt T.

N Engl J Med. 2014 Feb 6;370(6):533-42. doi: 10.1056/NEJMoa1206605.

47.

Enhanced membrane protein expression by engineering increased intracellular membrane production.

Guerfal M, Claes K, Knittelfelder O, De Rycke R, Kohlwein SD, Callewaert N.

Microb Cell Fact. 2013 Dec 9;12:122. doi: 10.1186/1475-2859-12-122.

48.

Capillary electrophoresis of urinary prostate glycoproteins assists in the diagnosis of prostate cancer.

Vermassen T, Van Praet C, Vanderschaeghe D, Maenhout T, Lumen N, Callewaert N, Hoebeke P, Van Belle S, Rottey S, Delanghe J.

Electrophoresis. 2014 Apr;35(7):1017-24. doi: 10.1002/elps.201300332. Epub 2013 Dec 20.

PMID:
24254641
49.

Characterization of a type D1A EUL-related lectin from rice expressed in Pichia pastoris.

Al Atalah B, Vanderschaeghe D, Bloch Y, Proost P, Plas K, Callewaert N, Savvides SN, Van Damme EJ.

Biol Chem. 2014 Apr;395(4):413-24. doi: 10.1515/hsz-2013-0267.

PMID:
24231122
50.

Structure of Ostertagia ostertagi ASP-1: insights into disulfide-mediated cyclization and dimerization.

Borloo J, Geldhof P, Peelaers I, Van Meulder F, Ameloot P, Callewaert N, Vercruysse J, Claerebout E, Strelkov SV, Weeks SD.

Acta Crystallogr D Biol Crystallogr. 2013 Apr;69(Pt 4):493-503. doi: 10.1107/S0907444912050019. Epub 2013 Mar 9.

PMID:
23519657

Supplemental Content

Loading ...
Support Center